The Controlled Substances Act and DEA schedules

The Controlled Substances Act: Background

The Controlled Substances Act (CSA), Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970, is the federal law that governs the manufacture, distribution, dispensing, and possession of drugs with potential for abuse or dependence. The Drug Enforcement Administration (DEA), a division of the Department of Justice, enforces the CSA. Every pharmacy that handles controlled substances must hold a valid DEA registration, and understanding the five-schedule system is a core pharmacy technician competency.

The Five DEA Schedules

Schedule I (C-I)

Schedule I drugs have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse. They may not be prescribed, dispensed, or administered in routine clinical care. Research use requires a separate DEA Schedule I researcher registration. Examples include heroin, lysergic acid diethylamide (LSD), and marijuana under federal law (state law varies, but federal scheduling controls federal registrants).

Schedule II (C-II)

Schedule II drugs have a high potential for abuse that may lead to severe psychological or physical dependence, but they do have accepted medical uses. This is the most tightly regulated prescription category:

• No refills permitted under federal law.
• A written or electronic prescription is required. Emergency oral prescriptions are allowed in limited circumstances but must be followed by a written prescription within a timeframe set by DEA regulations.
• Partial fills are permitted under certain conditions (e.g., the prescriber authorizes it, or the patient is in a long-term care facility or has a terminal illness).
• Must be stored in a substantially constructed locked cabinet or dispersed throughout non-controlled stock in a way that deters theft.

Examples: oxycodone, hydrocodone combination products (≥ 15 mg hydrocodone per dosage unit), fentanyl, amphetamine, methylphenidate, cocaine (topical/surgical use), and methadone.

Schedule III (C-III)

Schedule III drugs have a lower potential for abuse than Schedule II and accepted medical uses. Abuse may lead to moderate or low physical dependence or high psychological dependence.

• Up to 5 refills in 6 months are permitted.
• May be prescribed orally, in writing, or electronically.

Examples: buprenorphine (as used in opioid treatment), anabolic steroids, ketamine, and combination products containing lower doses of certain opioids (e.g., acetaminophen with codeine, Tylenol with Codeine No. 3).

Schedule IV (C-IV)

Schedule IV drugs have a lower potential for abuse than Schedule III, accepted medical uses, and limited physical or psychological dependence risk.

• Up to 5 refills in 6 months are permitted.

Examples: benzodiazepines (alprazolam, diazepam, lorazepam), zolpidem, carisoprodol, tramadol, and phenobarbital.

Schedule V (C-V)

Schedule V drugs have the lowest abuse potential among controlled substances and accepted medical uses. Some states allow certain Schedule V products (e.g., cough preparations containing small amounts of codeine) to be dispensed without a prescription, subject to strict state law requirements and pharmacist oversight. Federal law still requires a valid prescription in most cases; always follow the stricter of federal or state law.

Examples: pregabalin, lacosamide, and cough preparations with fewer than 200 mg of codeine per 100 mL.

Registrant Roles

Every pharmacy, prescriber, and manufacturer that handles controlled substances must register with the DEA and receive a unique DEA registration number. As a technician, you will frequently verify prescriber DEA numbers. A DEA number follows a specific alphanumeric format; pharmacies often use a formula to verify the number's authenticity as a basic fraud check. Technicians do not independently verify DEA numbers as a security gate—that is the pharmacist's responsibility—but recognizing the format helps flag potential forgeries for pharmacist review.

Storage and Security Requirements

All controlled substances must be stored in a securely locked, substantially constructed cabinet. Schedule II drugs are frequently stored separately. Perpetual inventory records (biennial inventory is the federal minimum) must be maintained. Any theft or significant loss must be reported to the DEA promptly using the appropriate reporting mechanism.

Patient Safety and Scope of Practice

Controlled substances carry significant risks: addiction, diversion, overdose, and drug interactions. Key safety points for technicians:

• Never dispense a controlled substance without a valid, verified prescription reviewed and approved by the pharmacist.
• Flag any prescription that appears altered, has unusual quantities, or comes from an unknown or suspicious prescriber for pharmacist review immediately.
• Maintain accurate counts; discrepancies must be reported to the pharmacist at once.
• Counsel on controlled substances is the pharmacist's responsibility; technicians should direct all patient questions to the pharmacist.
• Know your state's specific rules—states may place drugs in more restrictive schedules or add requirements beyond federal law. Always apply the stricter standard.

Why This Matters for the PTCE and ExCPT

Both certification exams test controlled substance law under Federal Requirements (PTCE) and the Technician's Role/Law domain (ExCPT). Expect questions about which schedule permits refills, which requires a written prescription, and how storage differs by schedule. Knowing where commonly prescribed drugs fall in Schedules II–V is essential.